☆ 4.7 Article

Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Biochemistry & Molecular Biology

Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review

Daniele Focosi et al.

Summary: The accelerated evolution of SARS-CoV-2 under selective pressure from neutralizing antibody-based therapeutics is a concern with potentially serious implications for public health. Studies have shown specific mutations after monoclonal antibody treatment and deletions in the spike protein after COVID-19 convalescent plasma therapy. Continuous genomic monitoring is needed to understand immune escape frequencies and the fitness of emerging variants among non-responders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant

Yu Gao et al.

Summary: This study found that SARS-CoV-2 spike-specific CD4(+) and CD8(+) T cells induced by prior infection or BNT162b2 vaccination provide extensive immune coverage against the Omicron variant. Additionally, T cells induced by BNT162b2 vaccination exhibit higher cross-reactivity to the Omicron variant compared to T cells induced by prior SARS-CoV-2 infection.

NATURE MEDICINE (2022)

添加到收藏夹

Letter Immunology

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma

Yingdan Wang et al.

EMERGING MICROBES & INFECTIONS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Immunity to SARS-CoV-2 up to 15 months after infection

Harold Marcotte et al.

Summary: This study monitored the immune response in COVID-19 patients up to 15 months after symptom onset. It found that the IgG antibody response and plasma neutralizing titers gradually decreased over time but stabilized after 6 months. SARS-CoV-2-specific memory B and T cells persisted in the majority of patients up to 15 months, but there was a significant decrease in specific T cells between 6 and 15 months. Some variants of concern may partially escape the neutralizing activity of plasma antibodies.

ISCIENCE (2022)

添加到收藏夹

Review Environmental Sciences

SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity

Stefan Pilz et al.

Summary: Seroprevalence surveys indicate that a significant proportion of the global population has been infected with SARS-CoV-2, and natural immunity plays a crucial role in protecting against reinfections and severe disease. National surveys show that previous infection provides a reduced risk of reinfection for at least one year, with moderate waning immunity. Natural immunity appears to have similar effectiveness against different SARS-CoV-2 variants, except for the Omicron variant which requires further study. Observational studies suggest that natural immunity may provide equal or greater protection compared to two doses of mRNA vaccines, although data are not consistent. Combining previous infection with vaccination seems to offer the greatest protection against SARS-CoV-2, but there are still knowledge gaps in this area.

ENVIRONMENTAL RESEARCH (2022)

添加到收藏夹

Article Oncology

Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease

Marie Bleakley et al.

Summary: This study evaluated the impact of T-N depletion on chronic GVHD (cGVHD) and other outcomes. The results showed that T-N depletion significantly reduced the incidence of GVHD without increasing the risk of relapse and nonrelapse mortality.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy

Giulia Berzero et al.

Summary: The study found that using JCPyV-specific T cell therapy to treat hematological patients with PML is safe and effective, with no treatment-related adverse events observed. Some patients experienced an increase in JCPyV-specific lymphocytes and a decrease in JCPyV viral load in cerebrospinal fluid. Six out of 9 patients achieved PML control, with 5 alive and in good clinical condition at their last follow-up.

ANNALS OF NEUROLOGY (2021)

添加到收藏夹

Editorial Material Immunology

T Cell Memory: Understanding COVID-19

Nicholas N. Jarjour et al.

Summary: This primer discusses the fundamental features of T cell memory and their potential relevance for effective immunity to SARS-CoV-2, as the focus shifts towards establishing natural and vaccine-induced immunity against COVID-19.

IMMUNITY (2021)

添加到收藏夹

Review Clinical Neurology

Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease

Irene Cortese et al.

Summary: The Review provides an overview of progressive multifocal leukoencephalopathy and diseases caused by JC virus, discussing emerging immunotherapeutic approaches for increased survival. It highlights the need to reassess PML pathophysiology and clinical course, and the challenges of reversing underlying immunosuppression in the absence of antiviral therapies. Emerging treatments show promise but caution is advised to manage potential complications such as immune reconstitution inflammatory syndrome and long-term neurological effects.

NATURE REVIEWS NEUROLOGY (2021)

添加到收藏夹

Article Hematology

Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses

Vanessa A. Fabrizio et al.

Summary: Adoptive cell therapy using CMV-CTLs has shown efficacy in posttransplant patients. There was no significant correlation between response to CMV-CTL therapy and immune reconstitution. Baseline endogenous immunity may play a role in improving CMV-related and overall survival outcomes.

BLOOD ADVANCES (2021)

添加到收藏夹

Article Immunology

COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses

Agnes Bonifacius et al.

Summary: Research showed that active COVID-19 patients had high levels of anti-SARS-CoV-2 nucleocapsid and spike IgG, but overall reduced antiviral T cell responses due to inflammatory environment, expression of inhibitory molecules, and effector caspase activity in T cells.

IMMUNITY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni et al.

NATURE (2021)

添加到收藏夹

Article Immunology

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection

Nina Le Bert et al.

Summary: The efficacy of virus-specific T cells in clearing pathogens involves a delicate balance between antiviral and inflammatory responses. Asymptomatic individuals clearing SARS-CoV-2 showed increased production of IFN-gamma and IL-2, along with a proportional secretion of IL-10 and proinflammatory cytokines, while symptomatic individuals displayed a disproportionate secretion of inflammatory cytokines triggered by SARS-CoV-2-specific T cell activation.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

A phase I/II dose-escalation single center study to evaluate the safety of infusion of memory t cells as adoptive therapy in coronavirus pneumonia and /or lymphopenia (release)

A. Perez-Martinez et al.

CYTOTHERAPY (2021)

添加到收藏夹

Article Immunology

Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease

Laura Bergamaschi et al.

Summary: The kinetics of immune changes in COVID-19 across different severity groups show that early bystander CD8(+) T cell immune response is prominent in asymptomatic or mild diseases, while severe cases have persistent cellular abnormalities and immune defects, which may increase clinical risks.

IMMUNITY (2021)

添加到收藏夹

Article Medicine, General & Internal

Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?

Daniel Gussarow et al.

Summary: Recovery from COVID-19 does not completely prevent reinfection, but establishes long-term immune protection. Vaccination efforts are ongoing globally, underscoring the importance of studying the immune mechanisms of SARS-CoV-2.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Article Clinical Neurology

Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal Leukoencephalopathy

Franziska Hopfner et al.

Summary: Through clinical studies, researchers have found that allogeneic transplant of BKV-CTL can significantly improve symptoms, reduce brain MRI changes, and decrease viral load in patients with PML.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

添加到收藏夹

Article Cell Biology

Single-cell analysis reveals cell communication triggered by macrophages associated with the reduction and exhaustion of CD8+ T cells in COVID-19

Lei He et al.

Summary: This study conducted a comprehensive analysis and evaluation of the severity of COVID-19 patients, including inflammatory damage parameters, T cell counts, and single-cell RNA sequencing data. Additionally, by analyzing the functional diversity of macrophages post-infection and the cytokine panel, potential targets for improving the efficacy of COVID-19 therapy were identified.

CELL COMMUNICATION AND SIGNALING (2021)

添加到收藏夹

Review Immunology

SARS-CoV-2-specific T cells in infection and vaccination

Antonio Bertoletti et al.

Summary: Virus-specific T cells during SARS-CoV-2 infection can play a dual role in either protection or pathogenesis, highlighting the importance of studying the function of these cells for future therapeutic and preventative strategies.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity

Lorena Vigon et al.

Summary: By analyzing cellular immune response parameters of COVID-19 patients, the study found that critically ill COVID-19 patients exhibited a strong inflammatory response, but inefficient immune response. The effective cytotoxic response was identified as a key feature in predicting COVID-19 severity.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)

A. Perez-Martinez et al.

Summary: The preliminary clinical trial results of treating COVID-19 patients with convalescent CD45RA- memory T cells show improvement in clinical status and no serious adverse events, suggesting the feasibility and safety of this treatment approach.

ECLINICALMEDICINE (2021)

添加到收藏夹

Letter Hematology

Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date

Brian Hanley et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Alba Grifoni et al.

CELL (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes

M. J. Steinhardt et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage

Jingyuan Liu et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

添加到收藏夹

Review Immunology

Immune Response, Inflammation, and the Clinical Spectrum of COVID-19

Luis F. Garcia

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Hematology

BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation

Eduardo Espada et al.

BLOOD ADVANCES (2020)

添加到收藏夹

Article Infectious Diseases

A minimal common outcome measure set for COVID-19 clinical research

J. C. Marshall et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Immunology

Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Yanchun Peng et al.

NATURE IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19

Petra Bacher et al.

IMMUNITY (2020)

添加到收藏夹

Article Immunology

T cell responses in patients with COVID-19

Zeyu Chen et al.

NATURE REVIEWS IMMUNOLOGY (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19

Man Kong et al.

EPIDEMIOLOGY AND INFECTION (2020)

添加到收藏夹

Review Oncology

Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation

Theresa Kaeuferle et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes

Maren Bieling et al.

ONCOTARGET (2018)

添加到收藏夹

Article Medicine, General & Internal

What is established in cell therapies? Possibilities and limits in immuno-oncology

A. Quaiser et al.

INTERNIST (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Unique features and clinical importance of acute alloreactive immune responses

Charlotte F. Inman et al.

JCI INSIGHT (2018)

添加到收藏夹

Article Oncology

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

M. Neuenhahn et al.

LEUKEMIA (2017)

添加到收藏夹

Article Hematology

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells

Barbara Withers et al.

BLOOD ADVANCES (2017)

添加到收藏夹

Article Immunology

Modulation of heme oxygenase-1 by metalloporphyrins increases anti-viral T cell responses

C. E. Bunse et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)

添加到收藏夹

Article Hematology

Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naive T Cells and Retain Functional Pathogen-Specific Memory T Cells

Marie Bleakley et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)

添加到收藏夹

Article Biophysics

Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis

D. Teschner et al.

BONE MARROW TRANSPLANTATION (2014)

添加到收藏夹

Article Biochemical Research Methods

Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches

Sabine Tischer et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2014)

添加到收藏夹

Article Medicine, Research & Experimental

Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells

Sabine Tischer et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2014)

添加到收藏夹

Article Immunology

Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease

Michael Uhlin et al.

CLINICAL INFECTIOUS DISEASES (2012)

添加到收藏夹

Article Hematology

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation

Eva Rettinger et al.

BLOOD (2011)

添加到收藏夹

Article Oncology

Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy

Lamia Aissi-Rothe et al.

JOURNAL OF IMMUNOTHERAPY (2010)

添加到收藏夹

Review Clinical Neurology

Progressive multifocal leukoencephalopathy and other forms of JC virus disease

Bruce J. Brew et al.

NATURE REVIEWS NEUROLOGY (2010)

添加到收藏夹

Article Hematology

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

T Feuchtinger et al.

BRITISH JOURNAL OF HAEMATOLOGY (2006)

添加到收藏夹

Review Immunology

The many important facets of T-cell repertoire diversity

J Nikolich-Zugich et al.

NATURE REVIEWS IMMUNOLOGY (2004)

添加到收藏夹

Article Biophysics

Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study

P Lewalle et al.

BONE MARROW TRANSPLANTATION (2003)

添加到收藏夹

Article Immunology

Age-related decrease in adenovirus-specific T cell responses

M Sester et al.

JOURNAL OF INFECTIOUS DISEASES (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.